The Future of Genetic Risk Assessment: From Lab to Life
Modern medicine is rapidly advancing in its ability to assess an individual’s risk for developing various diseases through genetic testing. But with this power comes a crucial question: how do we responsibly communicate these findings to patients? A recent study, published March 23, 2026, in the American Journal of Human Genetics, offers a blueprint for navigating this complex landscape, demonstrating a 70%+ success rate in providing personalized risk information to thousands of individuals.
eMERGE Network Paves the Way
The research, conducted by a team from Cincinnati Children’s and the University of Cincinnati as part of the national eMERGE network, focused on returning “genome-informed risk assessments” to nearly 24,000 participants aged 3 to 75. These assessments covered 11 common health conditions, including asthma, type 1 and 2 diabetes, heart disease, and various cancers. The eMERGE network, funded by the National Human Genome Research Institute, combines DNA biorepositories with electronic medical record (EMR) systems to facilitate large-scale genetic research.
Polygenic Risk Scores: A New Level of Prediction
The study utilized “polygenic risk scores,” which estimate disease risk based on common genetic variations across the entire genome. Unlike traditional genetic testing that focuses on single-gene mutations, polygenic risk scores consider the combined effect of many genes, offering a more comprehensive picture of an individual’s predisposition. This approach acknowledges that many factors, both genetic and environmental, contribute to disease risk.
Communication Strategies: A Tiered Approach
Researchers employed a tiered communication strategy, tailoring the method of result delivery to the level of risk. Lower-risk results were shared via secure electronic messages or mail. Still, for nearly 5,000 individuals identified as having higher-risk findings, the team prioritized one-on-one conversations – conducted by phone, video, or in person – to ensure understanding and provide support. Approximately 79% of adults and 68% of children with higher-risk results received these personalized consultations.
When direct contact proved challenging, information was still added to the patient’s electronic medical record, along with details on how to reach the research team. This ensures the information is available to clinicians and patients, even if a direct conversation isn’t immediately possible.
Addressing Disparities in Access
The study as well highlighted disparities in access to these crucial conversations. Individuals with greater access to care and stability – such as higher education or homeownership – were more likely to successfully complete a one-on-one session. Insurance status also played a role. These findings underscore the need for health systems to develop more flexible and equitable methods for contacting and supporting patients, particularly those at higher risk.
Future Trends in Genomic Medicine
This research points to several key trends shaping the future of genomic medicine:
Increased Accessibility of Genetic Testing
As the cost of genetic testing continues to decrease, it will turn into increasingly accessible to a wider population. This will generate a massive amount of genetic data, creating both opportunities and challenges for healthcare systems.
Integration of Genomic Data into Electronic Health Records
The seamless integration of genomic data into EMRs is crucial for enabling personalized medicine. This will allow clinicians to consider an individual’s genetic predisposition when making treatment decisions.
Development of More Sophisticated Polygenic Risk Scores
Ongoing research is focused on refining polygenic risk scores to improve their accuracy and predictive power. This includes incorporating data from diverse populations to ensure equitable performance across all ethnic groups.
Enhanced Communication Strategies
Effective communication of genetic risk information is paramount. Future strategies will likely involve the utilize of artificial intelligence (AI) to personalize communication and provide tailored support to patients.
Pro Tip:
Don’t hesitate to ask your healthcare provider about the possibility of genetic testing if you have a family history of a particular disease. Understanding your genetic risk can empower you to produce informed decisions about your health.
Frequently Asked Questions
What is a polygenic risk score?
A polygenic risk score estimates your risk of developing a disease based on the combined effect of many genes.
Is genetic testing right for everyone?
Not necessarily. It’s best to discuss your individual risk factors and family history with your healthcare provider to determine if genetic testing is appropriate for you.
How is the eMERGE network contributing to genomic medicine?
eMERGE combines genetic data with electronic medical records to conduct large-scale research and develop strategies for implementing genomic medicine in clinical practice.
What are the ethical considerations surrounding genetic risk assessment?
Ethical considerations include ensuring patient privacy, avoiding discrimination, and providing appropriate counseling and support.
Learn more about the eMERGE network and its research findings at https://emerge-network.org/.
Want to stay informed about the latest advances in genomic medicine? Subscribe to our newsletter for regular updates and insights.
